Gold Standard/Elsevier launches consumer medication information in 12 foreign languages

Consumer medication information in 12 foreign languages

Gold Standard/Elsevier, a leading developer of drug information and medication management solutions, announced today the launch of MEDcounselor Languages, a module that provides trusted MEDcounselor consumer medication information in 12 foreign languages. The new MEDcounselor Languages will enable healthcare providers to help non-English speaking patients better understand their drug therapy, take their medications safely, and avoid potentially harmful errors.

Based on state regulations and customer requests, the new languages offered within MEDcounselor Languages include Arabic, Bengali, Chinese, Creole (Haitian), French, Japanese, Italian, Korean, Polish, Russian, Tagalog and Vietnamese - along with currently available Spanish and English. Additional languages will be available in 2011.

"MEDcounselor Languages help pharmacies and health systems meet the needs of culturally diverse populations while fulfilling government requirements and meaningful use criteria for Language Access Services," said Marianne Messer, President of Gold Standard. "By employing the power of MEDcounselor Languages, providers can enhance the care they provide, promote medication knowledge, compliance and safety, and help patients and their families to achieve better personal healthcare management."

Providers can experience MEDcounselor Languages by joining representatives from Gold Standard (booth #514) at the National Association of Chain Drug Stores' Pharmacy and Technology Conference (NACDS), Aug. 28-31, 2010, in San Diego, California.

MEDcounselor Languages are available as an added module to Gold Standard's Clinical Pharmacology, a point-of-care drug reference, and Alchemy, an integrated drug database and decision support engine.

MEDcounselor Languages offers peer-reviewed content on the most frequently used U.S. prescription and over-the-counter drugs (such as medication uses, interactions and side effects), printable patient handouts, and compliance with national standards for Consumer Medication Information (CMI).